Tag Archives: drug

God as a Drug: The Rise of American Megachurches

American megachurches use stagecraft, sensory pageantry, charismatic leadership and an upbeat, unchallenging vision of Christianity to provide their congregants with a powerful emotional religious experience, according to research from the University of Washington.

“The megachurches movement is one of the leading indicators of how American Christians exercise their faith these days, so therefore they should be understood,” said James Wellman, associate professor of American religion at the University of Washington. “And our study shows they’re doing a pretty effective job for their members, based on self-reports, contrary to public opinion that tends to pass them off as a type of consumerist religion. In fact, their members speak eloquently of their spiritual growth.” (more…)

Read More

Some Harmful Effects of Light at Night Can Be Reversed, Study Finds

COLUMBUS, Ohio – Chronic exposure to dim light at night can lead to depressive symptoms in rodents – but these negative effects can be reversed simply by returning to a standard light-dark cycle, a new study suggests.

While hamsters exposed to light at night for four weeks showed evidence of depressive symptoms, those symptoms essentially disappeared after about two weeks if they returned to normal lighting conditions.

Even changes in the brain that occurred after hamsters lived with chronic light at night reversed themselves after returning to a more normal light cycle. (more…)

Read More

Building Molecular ‘Cages’ to Fight Disease

UCLA-created nanoscale protein containers could aid drug, vaccine delivery

UCLA biochemists have designed specialized proteins that assemble themselves to form tiny molecular cages hundreds of times smaller than a single cell. The creation of these miniature structures may be the first step toward developing new methods of drug delivery or even designing artificial vaccines.

“This is the first decisive demonstration of an approach that can be used to combine protein molecules together to create a whole array of nanoscale materials,” said Todd Yeates, a UCLA professor of chemistry and biochemistry and a member of the UCLA–DOE Institute of Genomics and Proteomics and the California NanoSystems Institute at UCLA. (more…)

Read More

Study: Heart Damage after Chemo Linked to Stress in Cardiac Cells

COLUMBUS, Ohio – Blocking a protein in the heart that is produced under stressful conditions could be a strategy to prevent cardiac damage that results from chemotherapy, a new study suggests.

Previous research has suggested that up to a quarter of patients who receive the common chemotherapy drug doxorubicin are at risk of developing heart failure later in life. Exactly how that heart damage is done remains unclear.

In this study, scientists identified a protein called heat shock factor-1 (HSF-1) as a likely source of chemotherapy-related heart damage in mice and cell cultures. Heat shock factor-1 is known to be induced by stress – in this case, the chemotherapy treatment itself. (more…)

Read More

Homeland Security Chief Speaks About Challenges Facing U.S., Global Cooperation

The United States is stronger and more secure than it was prior to 9/11, but threats from overseas remain and must be proactively managed, said Secretary of Homeland Security Janet Napolitano, who visited campus April 16 for a public talk sponsored by the UCLA Burkle Center for International Relations.

In a globalized world, international cooperation is the key to identifying those who intend to do harm, she said, adding that threats to the global supply chain, the activities of drug and human smuggling organizations, and the prevalence of cyber-criminals who attempt to steal information and intellectual property and disrupt critical networks are among the major challenges facing the Department of Homeland Security. (more…)

Read More

Freezing Technique Exposes Molecule-to-Molecule Attachments

Researchers at Yale University have developed a new way of exposing the atomic attachments that keep complex molecules in precise alignment. The new method could provide insight into the mechanics of a variety of molecular structures, potentially aiding efforts to manipulate them for drug discovery and other purposes.

“The method appears likely to become a central tool for the characterization of processes that depend on supramolecular associations,” said Mark Johnson, a Yale chemistry professor and the principal investigator of the technique, which is described in a paper published this month in the journal Science. Supramolecular associations are interactions taking place between molecules, rather than within them. (more…)

Read More

In Lab, Pannexin1 Restores Tight Binding of Cells Lost in Cancer

*By studying tumor cell behavior in a novel “scaffold-free” 3-D system, researchers have determined that the protein Pannexin1 may play an important biomechanical role in binding tissues together, an effect that is lost in cancerous cells.*

PROVIDENCE, R.I. [Brown University] — First there is the tumor and then there’s the horrible question of whether the cancerous cells will spread. Scientists increasingly believe that the structural properties of the tumor itself, such as how tightly the tumor cells are packed together, play a decisive role in the progression of the disease. In a new study, researchers show that the protein Pannexin1, known to have tumor-suppressive properties, plays an important role in keeping the cells within a tissue closely packed together, an effect that may be lost with cancer.

“In healthy tissues, the recently discovered protein Pannexin1 may be playing an important role in upholding the mechanical integrity of the tissue,” said first author and Brown University M.D./Ph.D. student Brian Bao. “When we develop cancer, we lose Pannexin1 and we lose this integrity.” (more…)

Read More

Researchers Uncover How New Melanoma Drug Accelerates Secondary Skin Cancers

Patients with metastatic melanoma taking the recently approved drug vemurafenib (marketed as Zelboraf) responded well to the twice-daily pill, but some of them developed a different, secondary skin cancer.

Now, researchers at UCLA’s Jonsson Comprehensive Cancer Center, working with investigators from the Institute of Cancer Research in London, Roche and Plexxikon, have elucidated the mechanism by which the drug excels at fighting melanoma but also allows for the development of skin squamous-cell carcinomas. (more…)

Read More